APOE genotype-specific differences in human and mouse macrophage nitric oxide production
- 1 February 2004
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 147 (1-2) , 62-67
- https://doi.org/10.1016/j.jneuroim.2003.10.015
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Inflammation and Alzheimer's Disease: Relationships between Pathogenic Mechanisms and Clinical ExpressionExperimental Neurology, 1998
- Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2.Journal of Clinical Investigation, 1998
- Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative StressJournal of Neurochemistry, 1998
- Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease ProgressionBrain Pathology, 1998
- Modulation of Nitric Oxide Production in Human Macrophages by Apolipoprotein-E and Amyloid-Beta PeptideBiochemical and Biophysical Research Communications, 1997
- Nitric oxide production by human monocytes: evidence for a role of CD23Immunology Today, 1995
- Activation of Macrophages by Alzheimer β Amyloid PeptideBiochemical and Biophysical Research Communications, 1994
- Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.Proceedings of the National Academy of Sciences, 1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Endogenous nitric oxide: physiology, pathology and clinical relevanceEuropean Journal of Clinical Investigation, 1991